Angiopoietin-like protein 2 is associated with chronic kidney disease in a general Japanese population: The Hisayama Study

Circulation Journal

Volumn 77, Issue 9, 2013, Pages 2311-2317

  Usui, Tomoko ^a   Ninomiya, Toshiharu ^a   Nagata, Masaharu ^a   Takahashi, Otowa ^b   Doi, Yasufumi ^a   Hata, Jun ^a   Fukuhara, Masayo ^a   Kitazono, Takanari ^a   Oike, Yuichi ^b   Kiyohara, Yutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Albuminuria; Angiopoietin like protein 2; Chronic kidney disease; Cross sectional study; Epidemiology

Indexed keywords

ALBUMIN; ANGIOPOIETIN 2; ANGIOPOIETIN LIKE PROTEIN 2; C REACTIVE PROTEIN; CREATININE; HEMOGLOBIN A1C; UNCLASSIFIED DRUG;

ADULT; AGED; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; GENETIC HETEROGENEITY; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; TURBIDIMETRY;

AGED; ALBUMINURIA; ANGIOPOIETINS; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84882773029     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-1548     Document Type: Article

References (31)

1. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report. Kidney Int 2011; 80: 17-28.
2. Fried L, Solomon C, Shlipak M, Seliger S, Stehman-Breen C, Bleyer AJ, et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol 2004; 15: 3184-3191.
3. Shankar A, Sun L, Klein BE, Lee KE, Muntner P, Nieto FJ, et al. Markers of inflammation predict the long-term risk of developing chronic kidney disease: A population-based cohort study. Kidney Int 2011; 80: 1231-1238.
4. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in infammation and metabolic disease. Nat Rev Immunol 2011; 11: 85-97.
5. Kawamura R, Doi Y, Osawa H, Ninomiya T, Hata J, Yonemoto K, et al. Circulating resistin is increased with decreasing renal function in a general Japanese population: The Hisayama Study. Nephrol Dial Transplant 2010; 25: 3236-3240.
6. Zoccali C, Mallamaci F, Panuccio V, Tripepi G, Cutrupi S, Parlongo S, et al. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int Suppl 2003; 63: S98-S102.
7. Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimburger O, Zhang Z, Hoff C, et al. Adiponectin in renal disease: Relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 2004, 65: 274-281.
8. Axelsson J, Witasp A, Carrero JJ, Qureshi AR, Suliman ME, Heimburger O, et al. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD. Am J Kidney Dis 2007; 49: 237-244.
9. Manabe I. Chronic infammation links cardiovascular, metabolic and renal diseases. Circ J 2011; 75: 2739-2748.
10. Kim I, Moon SO, Koh KN, Kim H, Uhm CS, Kwak HJ, et al. Molecular cloning, expression, and characterization of angiopoietin-related protein: Angiopoietin-related protein induces endothelial cell sprouting. J Biol Chem 1999; 274: 26523-26528.
11. Tabata M, Kadomatsu T, Fukuhara S, Miyata K, Ito Y, Endo M, et al. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 2009; 10: 178-188.
12. Okada T, Tsukano H, Endo M, Tabata M, Miyata K, Kadomatsu T, et al. Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis. Am J Pathol 2010; 176: 2309-2319.
13. Sun H, Zheng JM, Chen S, Zeng CH, Liu ZH, Li LS. Enhanced expression of ANGPTL2 in the microvascular lesions of diabetic glomerulopathy. Nephron Exp Nephrol 2007; 105: e117-e123, doi:10.1159/000100493 (accessed April 1, 2013).
14. Ohmura T, Ueda K, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, et al. Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: The Hisayama Study. Diabetologia 1993; 36: 1198-1203.
15. Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K, et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: The Hisayama study. Stroke 2003; 34: 2349-2354.
16. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
17. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
18. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 7: 2089-2100.
19. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, et al. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Diabetol Int 2012; 3: 8-10.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
21. Saito I, Kokubo Y, Kiyohara Y, Doi Y, Saitoh S, Ohnishi H, et al. Prospective study on waist circumference and risk of all-cause and cardiovascular mortality: Pooled analysis of Japanese community-based studies. Circ J 2012; 76: 2867-2874.
22. Ohmori S, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, et al. Hyperinsulinaemia and blood pressure in a general Japanese population: The Hisayama Study. J Hypertens 1994; 12: 1191-1197.
23. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: The role of insulin resistance and the sym-pathoadrenal system. N Engl J Med 1996; 334: 374-381.
24. Kubo M, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Hirakata H, et al. Effect of hyperinsulinemia on renal function in a general Japanese population: The Hisayama study. Kidney Int 1999; 55: 2450-2456.
25. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria refects widespread vascular damage: The Steno hypothesis. Diabetologia 1989; 32: 219-226.
26. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, et al. A defnition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994; 89: 2462-2478.
27. Ago T, Kuroda J, Kamouchi M, Sadoshima J, Kitazono T. Patho-physiological roles of NADPH oxidase/nox family proteins in the vascular system: Review and perspective. Circ J 2011; 75: 1791-1800.
28. Sanz AB, Sanchez-Nino MD, Ramos AM, Moreno JA, Santamaria B, Ruiz-Ortega M, et al. NF-κB in renal inflammation. J Am Soc Nephrol 2010; 21: 1254-1262.
29. Mezzano S, Aros C, Droguett A, Burgos ME, Ardiles L, Flores C, et al. NF-κB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant 2004; 19: 2505-2512.
30. Choi SW, Kim HY, Lee YH, Ryu SY, Kweon SS, Rhee JA, et al. eGFR is associated with subclinical atherosclerosis independent of albuminuria: The Dong-gu Study. Atherosclerosis 2010; 212: 661-667.
31. Nakano T, Ninomiya T, Sumiyoshi S, Fujii H, Doi Y, Hirakata H, et al. Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: The Hisayama study. Am J Kidney Dis 2010; 55: 21-30.